VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic vaccine against hepatitis B (HBV). He is also involved in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company’s enveloped virus-like particle (eVLP) platform technology enables the development of eVLP vaccines that mimic virus presentation to provoke a human immune system. Lead candidates in the eVLP program include VBI-1901, an immunotherapeutic candidate for a glioblastoma vaccine, which is in a Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it is engaged in the development of vaccine platforms and products for licensing to pharmaceutical and biotech companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals SA The company also has a collaboration with the National Research Council of Canada to develop a pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. collaborates with Coalition For Epidemic Preparedness Innovations to promote vaccine candidates against variants of Covid-19. The company was previously known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.
You are interested in buying VBI Vaccines (VBIV) shares, Tutorial Guide
Do you want to buy VBI Vaccines (VBIV) shares on Nasdaq easily and through a broker with official regulation? Does it call your attention to be able to monetize your profits for the month and obtain interest in the stock market? Here I am going to show you how you can register an account with DeGiro , a regulated investment broker with low commissions, and how you can acquire shares in VBI Vaccines Inc. (VBIV) (VBIV) quickly and intuitively.
The method to follow is very simple :
- To begin we are going to register in DeGiro, an interface where we will be able to buy shares of the company VBI Vaccines Inc. (VBIV) with the ticker (VBIV).
- In this step we will add €€€ to then carry out the 1st investment.
- When we finally see the funds we have to locate the company VBI Vaccines through the ticker, that is VBIV.
- To finish we must indicate the number of shares that we are going to buy, the price and the type of order.
The checklist may have been a bit simple for you, so now you are going to see the entire procedure with images of each part:
How to register at the broker DEGIRO.
The first thing is to register in degiro through the following link :
It will ask us for an email, a name and a password to enter, and then we will continue with the link that they have sent us by email.
Now DeGiro will ask us for important information in order to accept our identity card . We must have at hand the passport, DNI (identity document) or driving document, your mobile or cell phone and the number of the bank account that we are going to use to make our 1st deposit. If you don’t know what this format is like, you can check this simple step-by-step that we have done at Educacep .
Once our account has been validated, we can enter money from the Deposit/Withdraw tab. We have the possibility of making a bank transaction that will take two to three days, or carry out the deposit quickly using Sofort, a 100% secure and 100% reliable payment gateway.
How to buy VBI Vaccines (VBIV) shares through DeGiro
When we have the money we will be able to get our first share. You can select the Place Order button in the corner, or explore in the DeGiro browser and type in the ticker. In the next screenshot you will see that I have used the Amazon ticker but in your case you should insert (VBIV), the VBI Vaccines ticker. As it is an action, we will see that the related businesses and companies are listed and there we will see to find VBI Vaccines. The fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case VBI Vaccines Inc. (VBIV) is listed on Nasdaq. This step is essential so make no mistake.
At the time of placing the order we must be attentive to the next . We have the possibility of proceeding to place a limit or market order. Imagine that you plan to buy a share of VBI Vaccines at 3.3300, but its price today is higher. With a limit order we are going to put the value at which we plan to make the purchase and until there are no shares for sale at a certain value, the purchase of the share will not be executed. With a market order, DeGiro will buy the number of shares that we have indicated at today’s selling price, which will be very close to the live listing price.
In one case or another it is very convenient that you look at the type of alignment: permanent or day . For example, in Spain, the stock market listing is in the morning and until 1:00 p.m., and in the United States it coincides with the afternoon schedule in Spain. If an order is permanent, it will last until it manages to be executed, but if you opt for the “of the day” option, when that day is over, if it has not been executed, it will be deleted from your history in Activity – Pending Orders.
I wish this simple tutorial helped you to buy shares in VBI Vaccines. Bye now.
|Name||Title||Payment||exercised||Year of birth|
|Mr. Jeffrey R. Baxter FCMA, FCMA||President, CEO and Director||772.29k||N/A||1961|
|Mr Christopher McNulty||CFO, Head of Bus. Devel. and manager||N/A||N/A||1977|
|Dr David Evander Anderson||Scientific Director||462.48k||N/A||1970|
|Dr. Francisco Diaz-Mitoma FRCPC, MD, Ph.D.||Medical director||491.41k||N/A||1955|
|nicole anderson||Director of Corporate Communications and Investor Relations||N/A||N/A||N/A|
|Mrs. Athena Kartsaklis||Senior Vice President of Finland, Chief Compliance Officer and Chief Financial Officer||N/A||N/A||1965|
|Mrs Nell Beattie||Bus Chief Officer||N/A||N/A||1988|
|Mr Avi Mazaltov||Global Manufacturing Director and General Manager of SciVac||N/A||N/A||1962|
|Mr Misha Nossov||Senior Vice President of Market Access and Commercial||N/A||N/A||N/A|
|Mr. T. Adam Buckley||Sr. Vice President of Bus. Devel.||N/A||N/A||1976|
Recent VBI Vaccines Events:
No events registered in Educacep